BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3872758)

  • 1. Anti-T cell antibodies in primary glomerulonephritis.
    Nakabayashi K; Arimura Y; Yoshida M; Nagasawa T
    Clin Nephrol; 1985 Feb; 23(2):74-80. PubMed ID: 3872758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serial changes of lymphocyte subpopulations, anti-T cell antibodies, and circulating immune complexes in patients with lupus nephritis, nephrotic syndrome and poststreptococcal acute glomerulonephritis (author's transl)].
    Nakabayashi K; Yoshida M; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1981 Mar; 23(3):253-63. PubMed ID: 6975844
    [No Abstract]   [Full Text] [Related]  

  • 4. T lymphocyte subsets and antilymphocyte antibodies in lupus nephritis.
    Patel R; Patel DR; Najera D
    Clin Nephrol; 1986 Aug; 26(2):83-6. PubMed ID: 2944680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-lymphocyte subsets in primary and secondary glomerulonephritis.
    Fornasieri A; Sinico R; Fiorini G; Goldaniga D; Colasanti G; Vendemia F; Gibelli A; D'Amico G
    Proc Eur Dial Transplant Assoc; 1983; 19():635-41. PubMed ID: 6224213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological analysis of the primary renal diseases and lupus nephritis].
    Osaki K; Uomizu K; Otsuka H; Morita T; Uemura S; Harada R; Otsuji Y; Hashimoto S
    Nihon Jinzo Gakkai Shi; 1985 Jan; 27(1):33-41. PubMed ID: 4010062
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis.
    Tung KS; Woodroffe AJ; Ahlin TD; Williams RC; Wilson CB
    J Clin Invest; 1978 Jul; 62(1):61-72. PubMed ID: 659639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in primary glomerular diseases.
    Dohi K; Yamada H; Takai M; Fujii Y; Ishikawa H
    Clin Nephrol; 1987 Jan; 27(1):11-4. PubMed ID: 3493102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulation in glomerulonephritis, Henoch--Schonlein purpura and lupus nephritis.
    Bannister KM; Drew PA; Clarkson AR; Woodroffe AJ
    Clin Exp Immunol; 1983 Aug; 53(2):384-90. PubMed ID: 6224610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus and IgA deficiency.
    Yewdall V; Cameron JS; Nathan AW; Neild G; Ogg CS; Williams DG
    J Clin Lab Immunol; 1983 Jan; 10(1):13-8. PubMed ID: 6827588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
    Andres GA; Accinni L; Beiser SM; Christian CL; Cinotti GA; Erlanger BF; Hsu KC; Seegal BC
    J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal change glomerulonephritis and focal glomerulosclerosis markers and 'in vitro' activity of peripheral blood mononuclear cell.
    Dall'Aglio P; Chizzolini C; Brigati C
    Proc Eur Dial Transplant Assoc; 1983; 19():673-8. PubMed ID: 6348758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytotoxic activity in primary glomerulonephritis: evidence for immune complex-mediated cytotoxicity.
    Charlesworth JA; Bowman C; Perl SI; Yasmeen D; Pussell BA
    J Clin Lab Immunol; 1981 Nov; 6(3):233-6. PubMed ID: 6978404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological mechanisms in glomerulonephritis. A short review and analysis of peripheral mononuclear cell subsets in IgA nephropathy and membranous glomerulonephritis.
    Pettersson E; von Willebrand E; Honkanen E
    Scand J Urol Nephrol Suppl; 1985; 90():29-34. PubMed ID: 3879379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberration of B and T cell subsets in patients with IgA nephropathy and membranous nephropathy.
    Suga T; Endoh M; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1984 Jun; 9(2):95-101. PubMed ID: 6398930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired T-lymphocyte colony formation in lipoid nephrosis.
    Matsumoto K; Okano K; Yoshizawa N; Harada M; Ohi H; Hatano M
    Clin Nephrol; 1985 Dec; 24(6):279-84. PubMed ID: 3878248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.